Cargando…

Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol

INTRODUCTION: Blood cholesterol is likely a risk factor for prostate cancer prognosis and use of statins is associated with lowered risk of prostate cancer recurrence and progression. Furthermore, use of statins has been associated with prolonged time before development of castration resistance (CR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siltari, Aino, Riikonen, Jarno, Koskimäki, Juha, Pakarainen, Tomi, Ettala, Otto, Boström, Peter, Seikkula, Heikki, Kotsar, Andres, Tammela, Teuvo, Helminen, Mika, Raittinen, Paavo V, Lehtimäki, Terho, Fode, Mikkel, Østergren, Peter, Borre, Michael, Rannikko, Antti, Marttila, Timo, Salonen, Arto, Ronkainen, Hanna, Löffeler, Sven, Murtola, Teemu J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Urology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058683/ https://www.ncbi.nlm.nih.gov/pubmed/35487730 http://dx.doi.org/10.1136/bmjopen-2021-050264

Ejemplares similares

Circulatory and prostatic tissue lipidomic profiles shifts after high-dose atorvastatin use in men with prostate cancer
por: Raittinen, Paavo, et al.
Publicado: (2020)

Antihypertensive drug use and prostate cancer-specific mortality in Finnish men
por: Siltari, Aino, et al.
Publicado: (2020)

Atorvastatin induces adrenal androgen downshift in men with prostate cancer: A post Hoc analysis of a pilot adaptive Randomised clinical trial
por: Raittinen, Paavo V.H., et al.
Publicado: (2021)

Improved renal cancer prognosis among users of drugs targeting renin-angiotensin system
por: Eskelinen, Tommi, et al.
Publicado: (2021)

Pharmacoepidemiological Evaluation in Prostate Cancer—Common Pitfalls and How to Avoid Them
por: Siltari, Aino, et al.
Publicado: (2021)

Role of Lipids and Lipid Metabolism in Prostate Cancer Progression and the Tumor’s Immune Environment
por: Siltari, Aino, et al.
Publicado: (2022)

Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study
por: Rannikko, Antti, et al.
Publicado: (2022)

Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users. A population-based cohort study
por: Peltomaa, A. I., et al.
Publicado: (2021)

Anti-epileptic drugs and prostate cancer-specific mortality compared to non-users of anti-epileptic drugs in the Finnish Randomized Study of Screening for Prostate Cancer
por: Salminen, Jukka K., et al.
Publicado: (2022)

Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial
por: Veitonmäki, Thea, et al.
Publicado: (2016)

Statin Use, Cholesterol Level, and Mortality Among Females With Breast Cancer
por: Murto, Mika O., et al.
Publicado: (2023)

Missingness in the expanded prostate cancer index short form (EPIC-26) – prevalence, patterns, and explanatory factors
por: Talvitie, Anna-Maija, et al.
Publicado: (2023)

Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer
por: Kaapu, Kalle J, et al.
Publicado: (2016)

Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer
por: Kinnunen, Pete T. T., et al.
Publicado: (2017)

Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over Time
por: Pylväläinen, Juho, et al.
Publicado: (2019)

Inverse Association between Statin Use and Cancer Mortality Relates to Cholesterol Level
por: Peltomaa, Antti I., et al.
Publicado: (2022)

The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth
por: Murtola, Teemu J., et al.
Publicado: (2012)

Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer
por: Murtola, Teemu J., et al.
Publicado: (2018)

Prostate cancer incidence in men with prostate‐specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer
por: Ola, Idris Olasunmbo, et al.
Publicado: (2022)

In Vitro Dissolution Methods for Hydrophilic and Hydrophobic Porous Silicon Microparticles
por: Mönkäre, Juha, et al.
Publicado: (2011)

Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men
por: Kaapu, Kalle J., et al.
Publicado: (2018)

Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis
por: Huhtala, Tuulia, et al.
Publicado: (2012)

Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation
por: Nätkin, Reetta, et al.
Publicado: (2023)

Rapid and Accurate Detection of Urinary Pathogens by Mobile IMS-Based Electronic Nose: A Proof-of-Principle Study
por: Roine, Antti, et al.
Publicado: (2014)

Human Prostate Tissue MicroRNAs and Their Predicted Target Pathways Linked to Prostate Cancer Risk Factors
por: Enwald, Max, et al.
Publicado: (2021)

Prostate Cancer–specific Survival After Radical Prostatectomy Is Improved Among Metformin Users but Not Among Other Antidiabetic Drug Users
por: Joentausta, Roni M., et al.
Publicado: (2021)

Does the cis/trans configuration of peptide bonds in bioactive tripeptides play a role in ACE-1 enzyme inhibition?
por: Siltari, Aino, et al.
Publicado: (2014)

Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study
por: Hietikko, Ronja, et al.
Publicado: (2020)

Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential
por: Fredsøe, Jacob, et al.
Publicado: (2020)

The relationship of trait-like compassion with epigenetic aging: The population-based prospective Young Finns Study
por: Dobewall, Henrik, et al.
Publicado: (2023)

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine
por: Nurminen, Anssi, et al.
Publicado: (2023)

Psychological recovery and well-being of spouses of patients with prostate cancer 5 years after primary treatment in Finland: a follow-up survey
por: Lehto, Ulla-Sisko, et al.
Publicado: (2023)

Reproductive history and blood cell DNA methylation later in life: the Young Finns Study
por: Harville, Emily W., et al.
Publicado: (2021)

Colonic Delivery of α‐Linolenic Acid by an Advanced Nutrient Delivery System Prolongs Glucagon‐Like Peptide‐1 Secretion and Inhibits Food Intake in Mice
por: Kamakura, Remi, et al.
Publicado: (2021)

Functional Polymorphisms in Oxytocin and Dopamine Pathway Genes and the Development of Dispositional Compassion Over Time: The Young Finns Study
por: Dobewall, Henrik, et al.
Publicado: (2021)

The relationship of socioeconomic status in childhood and adulthood with compassion: A study with a prospective 32-year follow-up
por: Saarinen, Aino I., et al.
Publicado: (2021)

Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial
por: Jambor, Ivan, et al.
Publicado: (2019)

The expanded prostate cancer index composite short form (EPIC-26) for measuring health-related quality of life: content analysis of patients’ spontaneous comments written in survey margins
por: Talvitie, Anna-Maija, et al.
Publicado: (2021)

Mycoplasma pneumoniae may cause dyspnoea and hospitalisations in young healthy adults
por: Metsälä, Riku, et al.
Publicado: (2021)

Management Practices During Perinatal Respiratory Transition of Very Premature Infants
por: Hallman, Mikko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mvqhnqq6aanqh5mhs9oc4appb0